ALB and acute respiratory distress syndrome: A retrospective study conducted by Kheir et al. found that higher albumin levels on admission were associated with significantly fewer adverse outcomes in COVID-19 patients, including a reduction in venous thromboembolism events, acute respiratory distress syndrome (ARDS) development, ICU admissions, and readmissions within 90 days [24].